BRMS1 expression in resected lung adenocarcinoma

by Galetta, Domenico, Pizzutilo, Pamela, Longo, Vito
Published in Transl Lung Cancer Res (2018)

Successful treatment of triple EGFR mutation T785A/L861Q/H297_E298 with afatinib

by Longo, Vito, Catino, Annamaria, Montrone, Michele, Pizzutilo, Pamela, Pesola, Francesco, Marech, Ilaria, Capone, Iolanda, Prelaj, Arsela, Galetta, Domenico
Published in Thorac Cancer (2021)

Breath Analysis: Comparison among Methodological Approaches for Breath Sampling

by Di Gilio, Alessia, Palmisani, Jolanda, Ventrella, Gianrocco, Facchini, Laura, Catino, Annamaria, Varesano, Niccolò, Pizzutilo, Pamela, Galetta, Domenico, Borelli, Massimo, Barbieri, Pierluigi, Licen, Sabina, de Gennaro, Gianluigi
Published in Molecules (2020)

Incidence of Infections and Predictors of Mortality During Checkpoint Inhibitor Immunotherapy in Patients With Advanced Lung Cancer: A Retrospective Cohort Study

by Bavaro, Davide Fiore, Pizzutilo, Pamela, Catino, Annamaria, Signorile, Fabio, Pesola, Francesco, Di Gennaro, Francesco, Cassiano, Sandro, Marech, Ilaria, Lamorgese, Vito, Angarano, Gioacchino, Monno, Laura, Saracino, Annalisa, Galetta, Domenico
Published in Open Forum Infect Dis (2021)

Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features

by Passaro, Antonio, Novello, Silvia, Giannarelli, Diana, Bria, Emilio, Galetta, Domenico, Gelibter, Alain, Reale, Maria Lucia, Carnio, Simona, Vita, Emanuele, Stefani, Alessio, Pizzutilo, Pamela, Stati, Valeria, Attili, Ilaria, de Marinis, Filippo
Published in Cancers (Basel) (2021)

Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review

by Bafunno, Daniela, Catino, Annamaria, Lamorgese, Vito, Del Bene, Gabriella, Longo, Vito, Montrone, Michele, Pesola, Francesco, Pizzutilo, Pamela, Cassiano, Sandro, Mastrandrea, Angelica, Ricci, Donata, Petrillo, Patrizia, Varesano, Niccolò, Zacheo, Antonella, Galetta, Domenico
Published in J Thorac Dis (2020)

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation

by Cortellini, Alessio, Ricciuti, Biagio, Tiseo, Marcello, Bria, Emilio, Banna, Giuseppe L, Aerts, Joachim GJV, Barbieri, Fausto, Giusti, Raffaele, Cortinovis, Diego L, Migliorino, Maria R, Catino, Annamaria, Passiglia, Francesco, Torniai, Mariangela, Morabito, Alessandro, Genova, Carlo, Mazzoni, Francesca, Di Noia, Vincenzo, Signorelli, Diego, Gelibter, Alain, Occhipinti, Mario Alberto, Rastelli, Francesca, Chiari, Rita, Rocco, Danilo, Inno, Alessandro, De Tursi, Michele, Di Marino, Pietro, Mansueto, Giovanni, Zoratto, Federica, Grossi, Francesco, Filetti, Marco, Pizzutilo, Pamela, Russano, Marco, Citarella, Fabrizio, Cantini, Luca, Targato, Giada, Nigro, Olga, Ferrara, Miriam G, Buti, Sebastiano, Scodes, Simona, Landi, Lorenza, Guaitoli, Giorgia, Della Gravara, Luigi, Tabbò, Fabrizio, Ricciardi, Serena, De Toma, Alessandro, Friedlaender, Alex, Petrelli, Fausto, Addeo, Alfredo, Porzio, Giampiero, Ficorella, Corrado
Published in J Immunother Cancer (2020)